{
  "trial_id": "NCT01175473",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Sex, Body Mass Index (BMI), Duration of Type 2 Diabetes Mellitus, HbA1c, Blood Pressure, Renal Function (Creatinine Clearance), Liver Function Tests (Alanine Aminotransferase, Total Bilirubin), Hemoglobin, Neutrophil Count, Platelet Count, Hepatitis B and C Status, HIV Status, History of Cardiovascular Events, History of Diabetic Retinopathy, History of Gastrointestinal Disease, History of Pancreatitis, Family History of Medullary Thyroid Cancer, Use of Other Antidiabetic Medications, Use of Systemic Glucocorticoids, History of Drug or Alcohol Abuse.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Glycosylated Hemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index (BMI)"
        ],
        [
          "Renal Function (Creatinine Clearance)",
          "Renal Function (Creatinine Clearance)"
        ],
        [
          "Liver Function Tests (Alanine Aminotransferase, Total Bilirubin)",
          "Liver Function Tests (Alanine Aminotransferase, Total Bilirubin)"
        ],
        [
          "Hemoglobin",
          "Hemoglobin"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Race/Ethnicity",
        "Area Under Plasma Glucose Concentration Curve From Time 0.5 Hours to 4.5 Hours (GLU-AUC0:30-4:30h)",
        "Postprandial Plasma Glucose (PPG) Excursion",
        "Pro-insulin AUC(0:30-4:30h)",
        "Insulin AUC(0:30-4:30h)",
        "C-Peptide AUC(0:30-4:30h)",
        "Glucagon AUC(0:30-4:30h)",
        "Peptide YY3-36 (PYY3-36) Concentration",
        "Obestatin Concentration"
      ],
      "remaining_candidate_features": [
        "Sex",
        "Duration of Type 2 Diabetes Mellitus",
        "Blood Pressure",
        "Neutrophil Count",
        "Platelet Count",
        "Hepatitis B and C Status",
        "HIV Status",
        "History of Cardiovascular Events",
        "History of Diabetic Retinopathy",
        "History of Gastrointestinal Disease",
        "History of Pancreatitis",
        "Family History of Medullary Thyroid Cancer",
        "Use of Other Antidiabetic Medications",
        "Use of Systemic Glucocorticoids",
        "History of Drug or Alcohol Abuse"
      ]
    },
    "processed-gen-response": "Age, Sex, Body Mass Index (BMI), Duration of Type 2 Diabetes Mellitus, HbA1c, Blood Pressure, Renal Function (Creatinine Clearance), Liver Function Tests (Alanine Aminotransferase, Total Bilirubin), Hemoglobin, Neutrophil Count, Platelet Count, Hepatitis B and C Status, HIV Status, History of Cardiovascular Events, History of Diabetic Retinopathy, History of Gastrointestinal Disease, History of Pancreatitis, Family History of Medullary Thyroid Cancer, Use of Other Antidiabetic Medications, Use of Systemic Glucocorticoids, History of Drug or Alcohol Abuse."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index, Duration of Diabetes, Baseline HbA1c, Fasting Plasma Glucose, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, HDL Cholesterol, LDL Cholesterol, Estimated Glomerular Filtration Rate (eGFR),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Glycosylated Hemoglobin (HbA1c)",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Area Under Plasma Glucose Concentration Curve From Time 0.5 Hours to 4.5 Hours (GLU-AUC0:30-4:30h)",
        "Postprandial Plasma Glucose (PPG) Excursion",
        "Pro-insulin AUC(0:30-4:30h)",
        "Insulin AUC(0:30-4:30h)",
        "C-Peptide AUC(0:30-4:30h)",
        "Glucagon AUC(0:30-4:30h)",
        "Peptide YY3-36 (PYY3-36) Concentration",
        "Obestatin Concentration"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Duration of Diabetes",
        "Fasting Plasma Glucose",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Cholesterol",
        "Triglycerides",
        "HDL Cholesterol",
        "LDL Cholesterol",
        "Estimated Glomerular Filtration Rate (eGFR)"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Body Mass Index, Duration of Diabetes, Baseline HbA1c, Fasting Plasma Glucose, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, HDL Cholesterol, LDL Cholesterol, Estimated Glomerular Filtration Rate (eGFR)"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, HbA1c, Fasting Plasma Glucose, Systolic Blood Pressure, Diastolic Blood Pressure, Duration of Diabetes, History of Cardiovascular Disease, History of Hypertension, History of Dyslipidemia.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Glycosylated Hemoglobin (HbA1c)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Area Under Plasma Glucose Concentration Curve From Time 0.5 Hours to 4.5 Hours (GLU-AUC0:30-4:30h)",
        "Postprandial Plasma Glucose (PPG) Excursion",
        "Pro-insulin AUC(0:30-4:30h)",
        "Insulin AUC(0:30-4:30h)",
        "C-Peptide AUC(0:30-4:30h)",
        "Glucagon AUC(0:30-4:30h)",
        "Peptide YY3-36 (PYY3-36) Concentration",
        "Obestatin Concentration"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Body Mass Index",
        "Fasting Plasma Glucose",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Duration of Diabetes",
        "History of Cardiovascular Disease",
        "History of Hypertension",
        "History of Dyslipidemia"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, HbA1c, Fasting Plasma Glucose, Systolic Blood Pressure, Diastolic Blood Pressure, Duration of Diabetes, History of Cardiovascular Disease, History of Hypertension, History of Dyslipidemia."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c, fasting plasma glucose, systolic and diastolic blood pressure, heart rate, medical history (including cardiovascular, hepatic, neurological, or endocrine disease), concomitant medications, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Glycosylated Hemoglobin (HbA1c)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Area Under Plasma Glucose Concentration Curve From Time 0.5 Hours to 4.5 Hours (GLU-AUC0:30-4:30h)",
        "Postprandial Plasma Glucose (PPG) Excursion",
        "Pro-insulin AUC(0:30-4:30h)",
        "Insulin AUC(0:30-4:30h)",
        "C-Peptide AUC(0:30-4:30h)",
        "Glucagon AUC(0:30-4:30h)",
        "Peptide YY3-36 (PYY3-36) Concentration",
        "Obestatin Concentration"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "fasting plasma glucose",
        "systolic and diastolic blood pressure",
        "heart rate",
        "medical history (including cardiovascular, hepatic, neurological, or endocrine disease)",
        "concomitant medications",
        "smoking status"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c, fasting plasma glucose, systolic and diastolic blood pressure, heart rate, medical history (including cardiovascular, hepatic, neurological, or endocrine disease), concomitant medications, smoking status."
  }
}